Similarly, in kidney disorders such as diabetic nephropathy, exosomes from adipose-derived stem cells have been shown to enhance autophagy flux, alleviate podocyte injury and improve symptoms in type 2 diabetic mice by inhibiting mTOR signaling activation. This evidence concerns the gene MTOR and type 2 diabetes mellitus.